These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13270444)

  • 1. The coagulation defect caused by tromexan therapy.
    DOUGLAS AS
    Clin Sci; 1955 Nov; 14(4):601-13. PubMed ID: 13270444
    [No Abstract]   [Full Text] [Related]  

  • 2. Mode of action of tromexan.
    HUNTER RB; TUDHOPE GR
    Lancet; 1953 Apr; 1(6765):821-3. PubMed ID: 13036185
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 4. The control of prothrombin activity with tromexan therapy.
    WEINER M; SIMSON G; BURNS JJ; STEELE JM; BRODIE BB
    Am J Med; 1953 Jun; 14(6):689-93. PubMed ID: 13057878
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
    SERT AS
    Tip Fak Mecm; 1954; 17(3):434-9. PubMed ID: 13226361
    [No Abstract]   [Full Text] [Related]  

  • 7. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethyl biscoumacetate (tromexan) in coronary artery disease.
    POLLITZER RS
    J S C Med Assoc; 1953 Mar; 49(3):66-8. PubMed ID: 13045283
    [No Abstract]   [Full Text] [Related]  

  • 9. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
    BURNS JJ; WEINER M; SIMSON G; BRODIE BB
    J Pharmacol Exp Ther; 1953 May; 108(1):33-41. PubMed ID: 13053419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulant therapy with tromexan].
    GARCIA TURIELLA R; GASPARY FV; TUERO PR; FERRER J
    Prensa Med Argent; 1953 Aug; 40(32):2093-2103. PubMed ID: 13088693
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tromexan therapy of thrombophlebitis].
    VUILLEUMIER P
    Praxis; 1952 Aug; 41(35):758-60. PubMed ID: 13003888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prophylaxis of thrombosis with tromexan in closed fractures of the leg].
    GLOOR F; SIGG B
    Praxis; 1950 Sep; 39(39):839-40. PubMed ID: 14786168
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulant therapy; tromexan and G-23350].
    MAROIS A; BROSSEAU C
    Laval Med; 1955 Sep; 20(7):940-51. PubMed ID: 13279212
    [No Abstract]   [Full Text] [Related]  

  • 14. Further pharmacologic aspects of tromexan (pelantan or ethyl biscumacetate).
    GRUBER CM; LEE KS; RIEDERS F
    Arch Int Pharmacodyn Ther; 1952; 90(4):488-97. PubMed ID: 12986946
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tromexan load-test in lead poisoning].
    SAITA G; GATTONI L
    Med Lav; 1955 Nov; 46(11):623-6. PubMed ID: 13308643
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombotic diseases, especially treatment with tromexan].
    LINDAHL O
    Sven Lakartidn; 1956 Jan; 53(4):185-98. PubMed ID: 13311786
    [No Abstract]   [Full Text] [Related]  

  • 17. [Real or apparent value of tromexan].
    HALSE T
    Dtsch Med Wochenschr; 1952 Dec; 77(52):1634-6. PubMed ID: 13043368
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with tromexan].
    WICKE G
    Arztl Wochensch; 1953 Aug; 8(33):782-8. PubMed ID: 13080079
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 20. Tromexan and dicoumarol.
    ILLINGWORTH DG
    Br Med J; 1951 Sep; 2(4732):646-8. PubMed ID: 14869675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.